Brief: Evgen Pharma HY Post-Tax Loss Of £1.5 Mln

Theracryf

31/10/2023 07:34

Oct 31 (Reuters) - Evgen Pharma PLC  EVG.L :
    * EVGEN PHARMA PLC - HY POST-TAX LOSS OF £1.5M (2022: £2.1M)
    * EVGEN PHARMA PLC - CASH RUNWAY REMAINS UNCHANGED TO END OF
2024
EXCLUDING FURTHER MILESTONES FROM STALICLA SA OUT-LICENSE
AGREEMENT

Source text for Eikon:  ID:nRSe7763Ra 
Further company coverage:  EVG.L 

 ((Reuters.Briefs@thomsonreuters.com;))